Northern Trust Corp Relay Therapeutics, Inc. Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,169,979 shares of RLAY stock, worth $4.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,169,979

Previous 938,266 24.7%

Holding current value

$4.59 Million

Previous $6.64 Million 27.43%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.12 - $6.8 $954,657 - $1.58 Million	231,713 Added 24.7%	1,169,979 $4.82 Million
Q3 2024 Nov 13, 2024	BUY	$6.23 - $9.51 $771,610 - $1.18 Million	123,854 Added 15.21%	938,266 $6.64 Million
Q2 2024 Aug 14, 2024	SELL	$5.9 - $8.02 $82,570 - $112,239	-13,995 Reduced 1.69%	814,412 $5.31 Million
Q1 2024 May 14, 2024	BUY	$7.5 - $12.07 $30,427 - $48,967	4,057 Added 0.49%	828,407 $6.88 Million
Q4 2023 Feb 13, 2024	BUY	$6.01 - $11.48 $138,181 - $263,948	22,992 Added 2.87%	824,350 $9.08 Million
Q3 2023 Nov 13, 2023	BUY	$8.24 - $12.97 $58,751 - $92,476	7,130 Added 0.9%	801,358 $6.74 Million
Q2 2023 Aug 11, 2023	SELL	$9.99 - $18.27 $781,158 - $1.43 Million	-78,194 Reduced 8.96%	794,228 $9.98 Million
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $148,095 - $224,709	-9,873 Reduced 1.12%	872,422 $14.4 Million
Q4 2022 Feb 13, 2023	BUY	$14.16 - $24.02 $912,753 - $1.55 Million	64,460 Added 7.88%	882,295 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $341,270 - $592,453	18,886 Added 2.36%	817,835 $18.3 Million
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $1.98 Million - $5.18 Million	148,598 Added 22.85%	798,949 $13.4 Million
Q1 2022 May 13, 2022	SELL	$20.26 - $32.36 $689,630 - $1.1 Million	-34,039 Reduced 4.97%	650,351 $19.5 Million
Q4 2021 Feb 08, 2022	BUY	$26.0 - $37.03 $2.82 Million - $4.02 Million	108,462 Added 18.83%	684,390 $21 Million
Q3 2021 Nov 15, 2021	BUY	$29.75 - $37.99 $1.6 Million - $2.04 Million	53,822 Added 10.31%	575,928 $18.2 Million
Q2 2021 Aug 13, 2021	BUY	$27.5 - $38.19 $2.14 Million - $2.98 Million	77,973 Added 17.56%	522,106 $19.1 Million
Q1 2021 May 12, 2021	BUY	$32.52 - $61.53 $2.87 Million - $5.43 Million	88,240 Added 24.79%	444,133 $15.4 Million
Q4 2020 Feb 11, 2021	SELL	$35.51 - $54.03 $76,879 - $116,974	-2,165 Reduced 0.6%	355,893 $14.8 Million
Q3 2020 Nov 16, 2020	BUY	$32.81 - $45.1 $11.7 Million - $16.1 Million	358,058 New	358,058 $15.2 Million

Others Institutions Holding RLAY

# of Institutions

207

Shares Held

159M

Call Options Held

100K

Put Options Held

26.8K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $471M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Relay Therapeutics, Inc. Transaction History